Which companies overlap with Johnson & Johnson Consumer and Personal Products Worldwide's portfolio?

Top competitors by shared drug class: Bayer, Dr. Reddy's Laboratories Limited, EpiCept Corporation, Express Specialty Pharmacy, Georg Kägi, MD.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/johnson-johnson-consumer-and-personal-products-worldwide.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Johnson & Johnson Consumer and Personal Products Worldwide — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Johnson & Johnson Consumer and Personal Products Worldwide pipeline: 6 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

6 marketed 0 filed 2 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Colloidal Oatmeal Cream	Colloidal Oatmeal Cream	marketed	Topical emollient and skin protectant		Dermatology
Pain Relief Ointment	Pain Relief Ointment	marketed	Topical analgesic		Pain Management
ibuprofen; pseudoephedrine HCl	ibuprofen; pseudoephedrine HCl	marketed	NSAID + sympathomimetic decongestant combination	COX-1/COX-2 (ibuprofen); alpha-adrenergic receptors (pseudoephedrine)	Pain Management / Cold & Allergy
Colgate® Regular Cavity Protection	Colgate® Regular Cavity Protection	marketed
acetaminophen extended release caplets	acetaminophen extended release caplets	marketed
loperamide-simethicone	loperamide-simethicone	marketed	Antidiarrheal combination agent	Mu-opioid receptor (loperamide component); antifoaming agent (simethicone component)	Gastroenterology
Espumisan	Espumisan	phase 3			Other
Imonogas	Imonogas	phase 3			Other

Therapeutic area mix

Other · 2
Dermatology · 1
Gastroenterology · 1
Pain Management · 1
Pain Management / Cold & Allergy · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Dr. Reddy's Laboratories Limited · 1 shared drug class
EpiCept Corporation · 1 shared drug class
Express Specialty Pharmacy · 1 shared drug class
Georg Kägi, MD · 1 shared drug class
Grünenthal GmbH · 1 shared drug class
Henry Ford Health System · 1 shared drug class
NeurogesX · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Johnson & Johnson Consumer and Personal Products Worldwide:

Cite this brief

Drug Landscape (2026). Johnson & Johnson Consumer and Personal Products Worldwide — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/johnson-johnson-consumer-and-personal-products-worldwide. Accessed 2026-05-17.